Intranasal stimulation for treatment of meibomian gland disease and blepharitis

    公开(公告)号:US10918864B2

    公开(公告)日:2021-02-16

    申请号:US15584956

    申请日:2017-05-02

    Applicant: Oculeve, Inc.

    Abstract: Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.

    CONTACT LENS FOR INCREASING TEAR PRODUCTION
    37.
    发明申请

    公开(公告)号:US20200030615A1

    公开(公告)日:2020-01-30

    申请号:US16595846

    申请日:2019-10-08

    Applicant: Oculeve, Inc.

    Abstract: Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.

    Implant delivery devices, systems, and methods

    公开(公告)号:US10537469B2

    公开(公告)日:2020-01-21

    申请号:US15649364

    申请日:2017-07-13

    Applicant: Oculeve, Inc.

    Abstract: Systems, devices, and methods for delivering an implant to the orbit. In some instances, the systems may include a delivery device having a tongue member and a handle. The delivery device may further include an ejector configured to deliver an implant from the tongue member. The delivery device may also include a piercing member configured to create an opening in tissue. The systems may further include a piercing member for creating an opening in tissue. In some instances, the piercing member may have a first blade member rotatably connected to a second blade member.

    Nasal stimulator device
    40.
    外观设计

    公开(公告)号:USD826420S1

    公开(公告)日:2018-08-21

    申请号:US29562793

    申请日:2016-04-28

    Applicant: Oculeve, Inc.

    Abstract: The design is the visual features of the NASAL STIMULATOR DEVICE shown in solid lines in the drawings, whether those features are of shape, configuration, ornament, or pattern, or are a combination of any of these features. Shading is used in the drawings to better illustrate the design. The portions of the article shown in stippled lines do not form part of the design.Drawings of the design are included.FIG. 1 is a front perspective view of the nasal stimulator device;FIG. 2 is a front elevation view thereof;FIG. 3 is a rear elevation view thereof;FIG. 4 is a right side elevation view thereof;FIG. 5 is a left side elevation view thereof;FIG. 6 is a top plan view thereof; andFIG. 7 is a bottom plan view thereof.

Patent Agency Ranking